✦ LIBER ✦

Synthesis, in silico, in vitro, and in vivo investigation of 5-[11C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2

✍ Scribed by Caballero, Julio; Muñoz, Camila; Alzate-Morales, Jans H.; Cunha, Susana; Gano, Lurdes; Bergmann, Ralf; Steinbach, Joerg; Kniess, Torsten

Book ID: 119234142
Publisher: Elsevier Science
Year: 2012
Tongue: French
Weight: 770 KB
Volume: 58
Category: Article
ISSN: 0223-5234
DOI: 10.1016/j.ejmech.2012.10.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

139 BAY 57-9352: an inhibitor of VEGFR-2

139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates anti-angiogenic activity in vitro and in vivo

✍ J. Elting; R. Jones; C. Carter; C. Flynn; G. Zhu; C. Damico; M. McHugh; B. Hibne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Tyrosine Kinase Inhibitors. 6. Structure

Tyrosine Kinase Inhibitors. 6. Structure−Activity Relationships among N- and 3-Substituted 2,2‘-Diselenobis(1H-indoles) for Inhibition of Protein Tyrosine Kinases and Comparative in Vitro and in Vivo Studies against Selected Sulfur Congeners

✍ Showalter, H. D. Hollis; Sercel, Anthony D.; Leja, Boguslawa M.; Wolfangel, Crai 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 477 KB

Synthesis of 5-11C]methyl-3-[[2(S)-azeti

Synthesis of 5-11C]methyl-3-[[2(S)-azetidinyl]methoxy]-pyridine, an analogue of A-85380 for in vivo studies of nicotinic receptor

✍ F. Karimi; M. Björkman; B. Långström 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Angiogenesis is an important process in cell development, especially in cancer. Vascular endothelial growth factor (VEGF) signaling is an important regulator of angiogenesis. Several therapies that act against VEGF signal transduction have been developed, including YN968D1, which is a potent inhibit

SAR of Carbon-Linked, 2-Substituted Puri

SAR of Carbon-Linked, 2-Substituted Purines: Synthesis and Characterization of AP23451 as a novel Bone-Targeted Inhibitor of Src Tyrosine Kinase With In Vivo Anti-Resorptive Activity

✍ William C. Shakespeare; Yihan Wang; Regine Bohacek; Terry Keenan; Raji Sundaramo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB